Aurobindo Pharma has received a GST order from the Deputy Commissioner for FY 2019-20 demanding a reversal of input tax credit and payment of a total of Rs. 7,09,25,346, including GST, interest, and penalty. The company plans to appeal this order, but it does not expect a material impact on its finances or operations.